Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Restless Legs Syndrome 1Prolactinoma 1Lymphoma, Follicular 1Hyperprolactinemia 1

Interventions

Cabergoline 6Dopamine Agonists 2ropinirole 1pasireotide 1Tissue Banks 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Lapatinib 1Early Intervention, Educational 1Dexamethasone 1DNA Methylation 1Clomiphene 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prolactinoma × ropinirole × Clear all
NCT03038308 2024-06-04

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Columbia University

Phase 1/2 Completed
16 enrolled 8 charts

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡